Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness

Table 3

Clinical profile of study population.

Variable	Mean	Standard deviation	Range
Age at onset (years)	14.2	7.4	4–34
Onset to BTXA(wks)	18.4	20.3	1–96
Spherical equivalent right eye	−1.22	2.85	−7.50 to +2.00
Spherical equivalent left eye	−0.97	2.80	−7.50 to +2.25
Follow-up period (mos)	12.3	4.8	7–24

BTXA: botulinum toxin A.